These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36434631)

  • 1. Was EU's COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations.
    Gandjour A
    BMC Health Serv Res; 2022 Nov; 22(1):1410. PubMed ID: 36434631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of future lockdown policies against the COVID-19 pandemic.
    Gandjour A
    Health Serv Manage Res; 2023 Feb; 36(1):51-62. PubMed ID: 35380480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value-based pricing of a COVID-19 vaccine.
    Gandjour A
    Q Rev Econ Finance; 2022 May; 84():1-8. PubMed ID: 34975265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EU's Ordering of COVID-19 Vaccine Doses: Political Decision-Making under Uncertainty.
    Gleißner W; Follert F; Daumann F; Leibbrand F
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
    Wang Y; Luangasanatip N; Pan-Ngum W; Isaranuwatchai W; Prawjaeng J; Saralamba S; Painter C; Briones JR; Teerawattananon Y
    Eur J Health Econ; 2023 Jul; 24(5):735-748. PubMed ID: 35951243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost-Effectiveness of a COVID-19 Vaccine in a Danish Context.
    Debrabant K; Grønbæk L; Kronborg C
    Clin Drug Investig; 2021 Nov; 41(11):975-988. PubMed ID: 34623627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.
    Fu Y; Zhao J; Wei X; Han P; Yang L; Ren T; Zhan S; Li L
    Front Public Health; 2022; 10():917732. PubMed ID: 35928479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies.
    Shaker M; Abrams EM; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2658-2668.e3. PubMed ID: 33711496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the cost-effectiveness of annual COVID-19 booster vaccination in South Korea using a transmission dynamic model.
    Choi W; Shim E
    Front Public Health; 2023; 11():1280412. PubMed ID: 38074736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study.
    Mar J; Ibarrondo O; Estadilla CDS; Stollenwerk N; Antoñanzas F; Blasco-Aguado R; Larrañaga I; Bidaurrazaga J; Aguiar M
    Pharmacoeconomics; 2024 Feb; 42(2):219-229. PubMed ID: 37910377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.
    Reddy KP; Fitzmaurice KP; Scott JA; Harling G; Lessells RJ; Panella C; Shebl FM; Freedberg KA; Siedner MJ
    Nat Commun; 2021 Oct; 12(1):6238. PubMed ID: 34716349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan.
    Morales-Zamora G; Espinosa O; Puertas E; Fernández JC; Hernández J; Zakzuk V; Cepeda M; Alvis-Gúzman N; Castañeda-Orjuela C; Paternina-Caicedo A
    Value Health Reg Issues; 2022 Sep; 31():101-110. PubMed ID: 35640462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the unit costs of COVID-19 vaccine delivery in Kenya.
    Orangi S; Kairu A; Ngatia A; Ojal J; Barasa E
    BMC Health Serv Res; 2022 Apr; 22(1):439. PubMed ID: 35379227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Hornberger J; Robertus K
    Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
    Si S; Zomer E; Fletcher S; Lee J; Liew D
    Vaccine; 2019 Aug; 37(35):5009-5015. PubMed ID: 31301916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of COVID-19 vaccination: A systematic review.
    Utami AM; Rendrayani F; Khoiry QA; Noviyanti D; Suwantika AA; Postma MJ; Zakiyah N
    J Glob Health; 2023 Jan; 13():06001. PubMed ID: 36637810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.